BSE filing, NSE: NIRLON. Summary written from the filing by ALFA Finder's alert engine.
Nirlon Ltd: key numbers
- Share price
- ₹631.90
- Market cap
- ₹5,695 Cr
- Revenue (annual)
- ₹669.2 Cr
- Net profit (annual)
- ₹346.0 Cr
- P/E (TTM)
- 15.9×Sector 34.0×
- Promoter holding
- 67.64%-0.01% QoQ
- FII holding
- 4.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nirlon Ltd
All →Nirlon Capital Structure Change
BSREP IV FPI Two Holdings (DIFC) Limited acquired 23,25,000 equity shares (2.58%) of Nirlon Ltd from InRe Fund II via an inter-se off-market transfer.
Nirlon Capital Structure Change
InRe Fund II acquired a 2.58% stake in Nirlon Limited through an open market transaction. The acquisition increases the combined holding of the acquirer and PAC to 15.06%.
Nirlon Promoter Selling: ₹0.12 Cr
Nirlon Ltd's promoter group entity, Shital Trading & Interiors Pvt. Ltd., sold 2,000 equity shares via a market sale. The transaction was valued at Rs.0.12 Crore.
- Value
- ₹0.12 Cr
Nirlon Board Meeting Date
Nirlon Ltd has scheduled a Board of Directors meeting for November 2, 2026, to consider unaudited financial results for the quarter and half-year ended September 30, 2026.
Nirlon Dividend
Nirlon Limited shareholders approved a final dividend of Rs. 15 per share for the fiscal year 2025-26 at their 67th Annual General Meeting.
Nirlon Annual General Meeting
Nirlon Ltd's AGM results confirm the approval of all four resolutions, including the declaration of a final dividend of Rs. 15 per equity share.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.